European Society of Cardiology (ESC)

This page includes news from the European Society of Cardiology (ESC). The ESC represents more than 95,000 men and women in the field of cardiology from Europe, the Mediterranean basin. It is the European umbrella cardiology organization, which includes the European Association of Percutaneous Cardiovascular Interventions (EAPCI), which hosts the large EuroPCR meeting; the European Heart Rhythm Society (EHRA); European Association of Cardiovascular Imaging (EACVI); European Association of Preventive Cardiology (EAPC); and the Association for Acute Cardiovascular Care (ACVC).

Ziad Ali, MD, explains the ILUMIEN IV trial results for OCT Vs. Angiography.

ILUMIEN IV: OCT adds value over angiography alone, fails to improve outcomes

Ziad Ali, MD, discusses the mixed results of the ILUMIEN IV trial comparing OCT vs angiography alone.

ACC President Hadley Wilson, MD, explained the impact of 4 key ESC 2023 IVUS and OCT intravascular imaging trials and wht thaey will l;ikely influence PCI guidelines. #ESC ESC23 #ESC2023 #ACC

Intravascular imaging for PCI gets a big boost from recent studies

ACC President Hadley Wilson, MD, explains the big impact four late-breaking studies on intravascular imaging may have on revising PCI guidelines.

Video of Christina Albert, MD, MPH chair, Department of Cardiology, Cedars-Sinai, explaining the changing approaches to sudden cardiac arrest. #SCA #SCD #ESC #ESC23 #ESC2023

Changing approaches to the treatment of sudden cardiac arrest

Preventing sudden cardiac arrest involves managing risk factors such as hypertension, hyperlipidemia and diabetes. We spoke to Christine Albert, MD, about this and much more at ESC 2023.

Gregg Stone, MD, discussing the value of IVUS and OCT over angiography along to guide PCI procedures and actually improve outcomes based on a 12,000 patient meta analysis presented at ESC 2023. #ESC #ESC23 #ESC2023

Intravascular imaging improves PCI outcomes in meta analysis

Gregg Stone, MD, discussing the value of IVUS and OCT over angiography to guide PCI procedures and actually improve outcomes based on a 12,000 patient meta analysis presented at ESC 2023.

Lung cancer cigarettes

Patients who quit smoking after PCI see key improvements in their cardiovascular health

This encouraged the study’s authors, who had feared any history of smoking on a regular basis would do permanent, irreversible damage to a patient's cardiovascular health. 

Video of Prof. Dr. Ralph Stephan von Bardeleben explaining the latest details from key tricuspid valve trials.

What new tricuspid valve data tell us about the future of patient care

What are the latest updates on treating tricuspid regurgitation? We spoke with a leading researcher at ESC Congress 2023 to find out. 

Vivek Reddy, MD, director of arrhythmia service and processor of medicine in cardiac electrophysiology, Mt. Sinai, New York, expolains the key takeaways from the ADVENT trial of pulsed field ablation at ESC 2023.

Pulsed field ablation shows potential to replace thermal ablation

Vivek Reddy, MD, explained that pulsed field ablation is associated with many benefits compared to the current standard of care in electrophysiology. 

PCI among older heart attack patients: Complete revascularization outperforms culprit-only approach

Some heart teams may only target the culprit lesions when treating older patients, but new research confirms this increases the risk of several unfavorable outcomes.